Sort   by:  
 Page size 
UnknownTreatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.
Not available
S-EPMC12273612 | biostudies-literature
UnknownAutologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.
Not available
S-EPMC4728433 | biostudies-literature
UnknownTowards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
Not available
S-EPMC10316775 | biostudies-literature
UnknownGBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
Not available
S-EPMC9362732 | biostudies-literature
UnknownTracking Parkinson's: Study Design and Baseline Patient Data.
Not available
S-EPMC4927877 | biostudies-literature
UnknownComparison of glottic views and intubation times in the supine and 25 degree back-up positions.
Not available
S-EPMC5112746 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
Sort   by:  
 Page size